Compare RAVE & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RAVE | DRIO |
|---|---|---|
| Founded | 1958 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.8M | 52.8M |
| IPO Year | 1995 | 2013 |
| Metric | RAVE | DRIO |
|---|---|---|
| Price | $3.07 | $7.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | 23.2K | ★ 26.2K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 11.76 | ★ 1559.02 |
| EPS | 0.15 | ★ 1.75 |
| Revenue | ★ $15,120,000.00 | $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | N/A | $47.58 |
| P/E Ratio | $20.73 | ★ $4.19 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $2.25 | $0.42 |
| 52 Week High | $3.75 | $17.74 |
| Indicator | RAVE | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 40.01 | 57.18 |
| Support Level | $3.03 | $7.18 |
| Resistance Level | $3.13 | $8.29 |
| Average True Range (ATR) | 0.15 | 0.83 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 19.53 | 81.84 |
Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn Franchising and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The corporate administration and other segments. The Pizza Inn Franchising segment accounts for the majority of the company's revenue. Geographically, it generates the majority of the revenue from the United States.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.